BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
16 hedge funds and large institutions have $3.11M invested in Better Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $2.77M → $3.11M (+$345K)
Holders
16
Holding in Top 10
–
Calls
$647K
Puts
$372K
Top Buyers
| 1 | +$178K | |
| 2 | +$33.7K | |
| 3 | +$26K | |
| 4 |
Millennium Management
New York
|
+$25K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$19K |
Top Sellers
| 1 | -$147K | |
| 2 | -$96K | |
| 3 | -$23K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.5K |